ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
56 announcements with these filters
Dabur India Limited received NCLT approval for the merger of Sesa Care Private Limited into the company. This integration strengthens Dabur's Ayurvedic hair care portfolio following an initial 51% CRPS acquisition.
Dabur India announced a board meeting on 04 Nov 2026 to consider Q1 FY27 unaudited results and interim dividend. No financial figures are disclosed in this advance notice.
Dabur India has submitted updated contact details for its Key Managerial Personnel (KMP) authorized for determining event materiality under Regulation 30(5) of SEBI LODR.
Dabur India Limited received an ESG Rating of 73 from NSE Sustainability Ratings & Analytics. The company is categorized as a Leader based on this independent assessment.
Dabur India reported negligible impact from Nepal flash floods on its subsidiary, Dabur Nepal Private Limited. Manufacturing plants remain fully operational despite minor distributor disruptions.
The Delhi High Court has extended the stay on the FSSAI order prohibiting Dabur from using the '100%' claim on certain food products until December 16, 2026.
Dabur India Limited announced that the Hon'ble NCLT has reserved its order regarding the proposed Scheme of Amalgamation with Sesa Care Private Limited.
Dabur India Ltd allotted 4,638 equity shares under its Employees Stock Option Scheme 2000. This follows the approval by the Nomination & Remuneration Committee.
Dabur India Limited has been assigned an ESG Rating of '63' by ESG Risk Assessments and Insights Limited. The company's rating category is classified as 'Strong'.
Dabur India announced the re-appointment of directors Rajiv Mehrishi and Saket Burman, and a tenure modification for director Mukesh Hari Butani.
Dabur India received a US FDA warning letter regarding its Silvassa plant following an earlier import alert. The impact is limited to minor private-label exports.
Dabur India Limited held its 51st Annual General Meeting on August 06, 2026. Shareholders considered financial statements, dividends, and director re-appointments.
FSSAI has issued a restriction on Dabur India Limited regarding the use of "100%" claims on specific food product packaging. The company is transitioning its labels accordingly.
Dabur India paid a penalty of Rs. 0.25 Crore regarding GST audit observations. The company confirmed no other financial impact.
Dabur India clarified in response to news reports that it is transitioning product labels following an FSSAI notice. The company maintains compliance with all regulatory frameworks.
Dabur delivered a strong Q1 FY27 with 10.6% consolidated revenue growth and 15% PAT increase, despite adverse weather and geopolitical headwinds.
Dabur India Limited filed its Security Cover Certificate for the quarter ended June 30, 2026, which is reported as 'Not Applicable' for its unsecured debentures.
Dabur India reported a 15% surge in consolidated net profit to ₹591 Crore and a 10.6% revenue increase to ₹3,764 Crore for the quarter ending June 2026.
Dabur India announced an internal management restructuring, resulting in three executives ceasing to be categorized as Senior Management Personnel while continuing their roles within the company.
Dabur delivered a robust Q1 FY27 with 10.6% consolidated revenue growth and 15% PAT growth. Management highlighted double-digit gains in HPC and Foods despite high inflation and geopolitical headwinds.
Dabur India reported a 10.6% rise in consolidated revenue to ₹3,764 Crore, with net profit surging 15% to ₹591 Crore for the first quarter.
Dabur India Ltd reported revenue from operations of ₹3,764 Cr (+10.6% YoY) and net profit of ₹586.2 Cr (+15.3% YoY) for Q1 FY27.
Dabur India Limited announces its AGM on August 6, 2026, to adopt financials and declare final dividend of Rs.5.50 per share. Director reappointments and cost auditor ratification are also on agenda.
Dabur India filed its BRSR for FY2025-26 with third-party assurance. The report covers ESG disclosures and operational sites, as mandated by SEBI.
Dabur India filed its Integrated Annual Report 2025-26 and AGM notice. The report highlights sustainability efforts under the theme 'Layer by Layer Towards Net Zero'.
Dabur expects double-digit revenue and profit growth for Q1 FY27. This update precedes the formal financial results to be approved by the Board.
US FDA has issued Import Alert 66-40 on Dabur’s Silvassa plant. The company says the sanction has no financial or operational impact.
US FDA issued an Import Alert on Dabur's Silvassa plant for data integrity lapses. The company says the impact is limited to private label products with insignificant revenue.
Dabur India clarified that USFDA observations at its Silvassa plant concern a small, low-revenue segment. The facility remains operational while the company implements corrective actions.
Dabur India allotted 2,62,216 equity shares following employee stock option exercises. The company's paid-up capital increased to approximately ₹177.40 Crore after this issuance.